Article
An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
14 Jan 2020
Abstract excerpt
Background: Nowadays, clinical treatment outcomes of patients with hepatocellular carcinoma (HCC) has been improved. However, due to the complexity of the molecular mechanisms, the recurrence rate and mortality in HCC inpatients are still at a high level. Therefore, there is an urgent need in screening biomarkers of HCC to show therapeutic effects and improve the prognosis. Methods: In this study, we aim to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
